Redcare Pharmacy Logo
NL0012044747
A2AR94
SAE.MU

Redcare Pharmacy

Caricamento quotazioni...

Previsioni

Acquista
  1
Mantieni
  0
Vendi
  0

Discussioni nella community

Non ci sono ancora discussioni su questo asset.

Avvia discussione

  • Redcare Pharmacy reaches over 15 million active customers and high customer retention

    Redcare Pharmacy reports more than 15 million active customers who ordered at least once in the past twelve months, and a reorder rate above 90 percent in the third quarter of 2026. The company still sees significant growth potential, particularly from the introduction of the e-prescription in Germany, where the online share of prescription drugs is currently only around two percent. Compared with countries like Sweden, which have much higher online penetration, the investment story remains attractive over the long term. » Altro su deraktionaer.de


  • Redcare Pharmacy: analysts raise price targets after Q3 data and see substantial upside potential

    Redcare Pharmacy benefits from stronger demand for electronic prescriptions and prescription drugs, prompting an upward revision of forecasts. Detailed Q3 figures confirmed analysts' optimism; Berenberg sets a price target of €102, Metzler raised its target to €145 and MPCM/Siering to €125. Siering increased EBIT forecasts but lowered the EPS rating and partly attributes the higher price target to accounting for the convertible bond as debt. The stock showed relative strength in a volatile market and attracted buyers after a pullback. » Altro su deraktionaer.de


  • Redcare Pharmacy grows strongly thanks to e-prescriptions in Germany

    Redcare Pharmacy is benefiting from the e-prescription boom: in the third quarter revenue rose 18% to €847 million, and sales of prescription medicines in Germany climbed 56% to €197 million. Adjusted EBITDA increased 68% to €28.7 million, the adjusted operating margin was 3.4%, and the group swung to an annual profit of €1 million (previous year: -€7 million). Management confirmed the full-year targets and expects 16–18% revenue growth for 2026 with an adjusted EBITDA margin of 2.5–3.0%. After the strong share-price rally, the stock came under short-term pressure from profit-taking. » Altro su finanzen.net


  • Redcare Pharmacy benefits from e-prescription boom, shares fall after profit-taking

    Redcare Pharmacy increased sales in the third quarter by 18% to €847 million and adjusted EBITDA by 68% to €28.7 million, slightly beating expectations. Despite the positive results, the shares fell about 3.2% to €76.70 in pre-market trading after profit-taking; they had previously risen 57% since mid-September. Analysts rated the figures positively, and Jefferies expects a further upward revision of the full-year outlook. » Altro su finanzen.net


  • Redcare Pharmacy beats forecasts with strong revenue and EBITDA growth

    In the third quarter Redcare Pharmacy’s revenue rose 18% to €847m, while adjusted EBITDA increased 68% to €28.7m, slightly above analyst expectations. The adjusted EBITDA margin was 3.4%; in the DACH region the margin improved year on year to 4.2%. The active customer base grew by 123,000 during the quarter, and management aims to further boost profitability through marketing optimisation and scale effects. Despite the positive numbers, the stock saw profit-taking. » Altro su deraktionaer.de

Dati finanziari dell'azienda

Nell'ultimo trimestre, Redcare Pharmacy ha registrato ricavi pari a 846,7 Mln € e un utile netto di 800K €
(EUR) settembre 2026
YoY
Ricavi 846,7 Mln 17,72%
Utile lordo 184,6 Mln 16,18%
Utile netto 800K 111,05%
EBITDA 28,3 Mln 72,67%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
1,19 Mld €
Numero di azioni
20,18 Mln
Massimo/minimo a 52 settimane
69,94 € - 41,08 €
Dividendi No
Beta
1,63
Rapporto P/E
-40,46
Rapporto PEG
16,90
Rapporto P/B
3,01
Rapporto P/S
0,41

Profilo aziendale

Shop Apotheke Europe N.V. possiede e gestisce farmacie online in Germania, Austria, Svizzera, Francia, Belgio, Italia e Paesi Bassi. Offre farmaci su prescrizione, farmaci da banco e prodotti di bellezza e cura della persona legati alla farmacia, oltre a integratori alimentari. La società è stata fondata nel 2001 e ha sede a Sevenum, nei Paesi Bassi.

Nome
Redcare Pharmacy
CEO
Peter Linstow
Sede centrale Sevenum, li
Paesi Bassi
Sito web
Settore
Sanità
Industria
Fornitori e servizi sanitari
Quotazione in borsa
13/10/2016
Dipendenti 1827

Simboli di borsa

Borsa Simbolo
München
SAE.MU
XETRA
SAE.DE
Düsseldorf
SAE.DU
Frankfurt
SAE.F
Hamburg
SAE.HM
London
0RJT.L
SIX
SAECHF.SW
Wien
SHOP.VI
Pnk
SHPPF
🍪

Parqet  usa i cookie. Scopri di più